452 related articles for article (PubMed ID: 27662187)
1. Obesity and ECG left ventricular hypertrophy.
Muiesan ML; Salvetti M; Di Castelnuovo A; Paini A; Assanelli D; Costanzo S; Badilini F; Vaglio M; Donati MB; Agabiti Rosei E; de Gaetano G; Iacoviello L;
J Hypertens; 2017 Jan; 35(1):162-169. PubMed ID: 27662187
[TBL] [Abstract][Full Text] [Related]
2. Correction of QRS voltage for body mass index does not improve the prediction of fatal and nonfatal cardiovascular events. The Moli-sani study.
Salvetti M; Paini A; Di Castelnuovo A; Assanelli D; Costanzo S; Gianfagna F; Badilini F; Vaglio M; Donati MB; de Gaetano G; Lorenza Muiesan M; Iacoviello L;
Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):426-433. PubMed ID: 31791640
[TBL] [Abstract][Full Text] [Related]
3. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
[TBL] [Abstract][Full Text] [Related]
4. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
[TBL] [Abstract][Full Text] [Related]
6. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
7. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
8. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.
Antikainen RL; Peters R; Beckett NS; Fagard RH; Wang JG; Rajkumar C; Bulpitt CJ
J Hypertens; 2016 Nov; 34(11):2280-6. PubMed ID: 27552643
[TBL] [Abstract][Full Text] [Related]
10. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus.
Okin PM; Roman MJ; Devereux RB; Kligfield P
J Electrocardiol; 1996; 29 Suppl():256-61. PubMed ID: 9238409
[TBL] [Abstract][Full Text] [Related]
11. ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population.
Porthan K; Niiranen TJ; Varis J; Kantola I; Karanko H; Kähönen M; Nieminen MS; Salomaa V; Huikuri HV; Jula AM
J Hypertens; 2015 Jun; 33(6):1284-90. PubMed ID: 25764049
[TBL] [Abstract][Full Text] [Related]
12. T-wave axis deviation and left ventricular hypertrophy interaction in diabetes and hypertension.
Assanelli D; Di Castelnuovo A; Rago L; Badilini F; Vinetti G; Gianfagna F; Salvetti M; Zito F; Donati MB; de Gaetano G; Iacoviello L;
J Electrocardiol; 2013; 46(6):487-91. PubMed ID: 24011993
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of body mass index-adjusted criteria for left ventricular hypertrophy.
Afify H; Lee HL; Soliman EZ; Singleton MJ
J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1476-1483. PubMed ID: 32762125
[TBL] [Abstract][Full Text] [Related]
14. Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population.
Cuspidi C; Facchetti R; Bombelli M; Sala C; Grassi G; Mancia G
J Hypertens; 2014 Apr; 32(4):921-8. PubMed ID: 24406778
[TBL] [Abstract][Full Text] [Related]
15. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
[TBL] [Abstract][Full Text] [Related]
17. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
[TBL] [Abstract][Full Text] [Related]
18. Correlation between echocardiographic left ventricular mass index and electrocardiographic variables used in left ventricular hypertrophy criteria in Chinese hypertensive patients.
Xie L; Wang Z
Hellenic J Cardiol; 2010; 51(5):391-401. PubMed ID: 20876051
[TBL] [Abstract][Full Text] [Related]
19. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population.
Tanaka K; Tanaka F; Onoda T; Tanno K; Ohsawa M; Sakata K; Omama S; Ogasawara K; Ishibashi Y; Itai K; Kuribayashi T; Okayama A; Nakamura M;
Am J Hypertens; 2018 Jul; 31(8):895-901. PubMed ID: 29659657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
